Posts for Category: ACMT News
-
American College of Medical Toxicology Members Working with Federal Agencies to Investigate Bleeding Complications from Synthetic Cannabinoid Use
An outbreak of major bleeding complications associated with synthetic cannabinoid use may be caused by brodifacoum and other related contaminants -
The American College of Medical Toxicology to Host 15th Annual Scientific Meeting in Washington DC April 5—8, 2018
ACMT’s 2018 Annual Scientific Meeting (ASM) will be held Friday, April 6—Sunday, April 8, at the Washington Marriott Georgetown in Washington DC. Our annual Satellite Session, 'Toxic Threats, Chemical Security, and Counterfeit Pharmaceuticals' will precede ASM on Thursday, April 5, at the same venue. -
The American College of Medical Toxicology Offers New ‘Total Tox Course’ for Emergency Providers
ACMT offers new comprehensive toxicological training for providers who see poisoned patients. ACMT’s Total Tox Course will be held at the Wyndham Grand Chicago Riverfront on Wednesday, September 5—Friday, September 7, 2018. -
The American College of Medical Toxicology to Host a One-Day Seminar ‘Toxic Threats, Chemical Security and Counterfeit Pharmaceuticals’ in Washington DC this April
ACMT’s 2018 Satellite Session, 'Toxic Threats, Chemical Security and Counterfeit Pharmaceuticals' will be held on Thursday, April 5, at the Washington Marriott Georgetown in Washington DC. -
The American College of Medical Toxicology Develops Quality Measures Approved by The Centers for Medicare & Medicaid Services
The Centers for Medicare & Medicaid Services (CMS) announced in late-December that they have approved six quality measures that were developed by the American College of Medical Toxicology (ACMT). These are the first-ever medical toxicology quality measures approved by CMS. -
The American College of Medical Toxicology (ACMT) Collaborates with Federal Agencies on ‘Fentanyl Safety Recommendations for First Responders’
A position statement regarding fentanyl exposure in first responders, published by the American College of Medical Toxicology (ACMT) and American Academy of Clinical Toxicology (AACT) in July 2017, continues to pave the way in clarifying risks of dermal and inhalation fentanyl exposure. -
Register Now for the American College of Medical Toxicology ‘Seminar in Forensic Toxicology: Opioids, Toxicology, and the Law’
Join the American College of Medical Toxicology (ACMT) and the Fredric Rieders Family Foundation at the 2017 Seminar in Forensic Toxicology 'Opioids, Toxicology, and the Law: Medical-Legal Aspects of the Opioid Epidemic' on Monday, December 11 and Tuesday, December 12, 2017, at the Chemical Heritage Foundation in Philadelphia, PA. -
Register Now for the 2017 Seminar in Forensic Toxicology ‘Opioids, Toxicology, and the Law: Medical-Legal Aspects of the Opioid Epidemic’
This unique conference will benefit health care professionals, scientists, social workers, attorneys, and law enforcement. -
ACMT Releases Safety Precautions for Emergency Responders in Case of Fentanyl Exposure
Fentanyl exposure safety precautions based on the experience of physicians who specialize in medical toxicology. -
Synthetic Cannabinoid Effects Detailed in 5 Year Study from the American College of Medical Toxicology ToxIC Registry Database —The Largest Clinical Report to Date
Synthetic cannabinoids (SCs), which are sold under hundreds of brand names including “spice” or “K2”, have become common drugs of abuse in the US. These man-made drugs are associated with severe central nervous system and cardiovascular effects.